State Wants Its Money Back

Connecticut officials are demanding that Alexion return the 26-million-dollars the state provided the company to relocate to New Haven.  

Alexion announced yesterday that it plans to relocate their headquarters from New Haven  to Boston, and says they will pay the state back.  

The rare disease  drug maker plans to leave 450 employees behind in Connecticut and move  400 others to Boston by next year.  

The New Haven headquarters that opened last year will become a research and development facility.

Sponsored Content

Sponsored Content